Verapamil and nifedipine in combination for the treatment of hypertrophy heart disease.
Kaesemeyer
W H
WH
Prisant
L M
LM
Carr
A A
AA
D000307:Adrenal Gland Diseases / Q000150:complications; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D002318:Cardiovascular Diseases / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D004359:Drug Therapy, Combination; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D006965:Hyperplasia / Q000150:complications; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D009543:Nifedipine / Q000627:therapeutic use*; D013148:Spironolactone / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use*
D013148:Spironolactone; D014700:Verapamil; D009543:Nifedipine